Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats
Erinacine A increases catecholamine and nerve growth factor content in the central nervous system of rats
复制标题
DOI:
10.1016/j.nutres.2005.06.001
复制
发表时间:
2005-06-01
影响因子:
4.5
通讯作者:
Yokogoshi, H
中科院分区:
文献类型:
--
作者:
Shimbo, M;Kawagishi, H;Yokogoshi, H
Nerve growth factor (NGF) is an essential protein for supporting growth and maintenance of peripheral sympathetic neurons. A novel diterpenoid erinacine, isolated from the cultured mycelia of Hericium erinacium, is known to have a potent stimulating effect on NGF synthesis. The effects of erinacine and related compounds in the brain in vivo are not known. In this study, we examined the effects of erinacine A on the production of NGF and catecholamines which stimulate NGF synthesis in the brain of rats. Rats were treated with erinacine A by intubation for the first 3 weeks from birth to weaning and intragastrically from weeks 4 to 5. Rats treated with this compound had increased levels of both noradrenaline and homovanillic acid in the locus coeruleus (LC) at 4 weeks of age and increased levels of NGF in both LC and hippocampus at 5 weeks of age. The effects of erinacine A were confirmed in the central nervous system in rats. (c) 2005 Elsevier Inc. All rights reserved.